Nantahala Capital Management’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,272,203
Closed -$10.2M 134
2023
Q2
$10.2M Sell
4,272,203
-3,419,610
-44% -$8.11M 1.23% 25
2023
Q1
$14.2M Sell
7,691,813
-90,205
-1% -$176K 1.36% 25
2022
Q4
$14.8M Buy
7,782,018
+2,566,230
+49% +$6.49M 1.34% 27
2022
Q3
$11.2M Buy
5,215,788
+72,933
+1% +$216K 1.09% 37
2022
Q2
$14.6M Buy
5,142,855
+796,528
+18% +$2.42M 1.26% 36
2022
Q1
$18.1M Buy
4,346,327
+268,818
+7% +$1.13M 1.25% 30
2021
Q4
$21.2M Buy
4,077,509
+1,140,718
+39% +$6.85M 1.32% 36
2021
Q3
$19.2M Buy
2,936,791
+1,143,291
+64% +$7.22M 1.14% 42
2021
Q2
$11.9M Buy
+1,793,500
New +$11.1M 0.66% 63

Other funds holding AUTL